Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

The introduction of the direct-acting antivirals (DAA) has substantially improved the effectiveness of the therapy in patients with chronic hepatitis C. We aimed to compare the efficacy of pangenotypic and genotype-specific DAA in the cohort of genotype (GT) four patients with HCV monoinfection and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarębska-Michaluk, Dorota, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna, Pawłowska, Małgorzata, Janczewska, Ewa, Berak, Hanna, Janocha-Litwin, Justyna, Klapaczyński, Jakub, Tomasiewicz, Krzysztof, Piekarska, Anna, Krygier, Rafał, Citko, Jolanta, Tronina, Olga, Dobrowolska, Krystyna, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781964/
https://www.ncbi.nlm.nih.gov/pubmed/35054088
http://dx.doi.org/10.3390/jcm11020389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781964/
https://www.ncbi.nlm.nih.gov/pubmed/35054088
http://dx.doi.org/10.3390/jcm11020389

Ejemplares similares